Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

NCT03756064 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Neoplasm, Breast
Breast Diseases

Interventions

DRUG: Pyrotinib
DRUG: Trastuzumab
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Placebo Oral Tablet

Sponsor

Zhejiang Cancer Hospital